These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 34089357)

  • 21. Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'.
    Perricone C; Bartoloni E; Cafaro G; Caporali R; Gerli R
    Ann Rheum Dis; 2023 Apr; 82(4):e81. PubMed ID: 33509794
    [No Abstract]   [Full Text] [Related]  

  • 22. Colchicine - From rheumatology to the new kid on the block: Coronary syndromes and COVID-19.
    Surma S; Basiak M; Romańczyk M; Filipiak KJ; Okopień B
    Cardiol J; 2023; 30(2):297-311. PubMed ID: 34642922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing your patient with gout: a review of treatment options.
    Doghramji PP
    Postgrad Med; 2011 May; 123(3):56-71. PubMed ID: 21566416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Inflammation, Immunomodulation and Therapeutic Repair in Current Clinical Trials for the Management of COVID-19.
    Li C; Zhao H; Cheng L; Wang B
    Drug Des Devel Ther; 2021; 15():1345-1356. PubMed ID: 33824579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of acute gout.
    Conway N; Schwartz S
    Med Health R I; 2009 Nov; 92(11):356-8. PubMed ID: 19999893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2020 Recommendations from the French Society of Rheumatology for the management of gout: Management of acute flares.
    Latourte A; Pascart T; Flipo RM; Chalès G; Coblentz-Baumann L; Cohen-Solal A; Ea HK; Grichy J; Letavernier E; Lioté F; Ottaviani S; Sigwalt P; Vandecandelaere G; Richette P; Bardin T
    Joint Bone Spine; 2020 Oct; 87(5):387-393. PubMed ID: 32422339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
    Bouayad A
    Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colchicine for acute gout.
    Schlesinger N; Schumacher R; Catton M; Maxwell L
    Cochrane Database Syst Rev; 2006 Oct; (4):CD006190. PubMed ID: 17054279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In Medea's gardens--two tales of colchicine].
    Huynh-Do U
    Ther Umsch; 2006 Dec; 63(12):783-7. PubMed ID: 17133301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colchicine and other drugs for gout.
    Med Lett Drugs Ther; 2009 Nov; 51(1326):93-4. PubMed ID: 20224523
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of gout and hyperuricemia.
    Wisner DE; Simkin PA
    Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
    Imazio M; Brucato A; Lazaros G; Andreis A; Scarsi M; Klein A; De Ferrari GM; Adler Y
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):625-629. PubMed ID: 32658005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.
    Oztas M; Bektas M; Karacan I; Aliyeva N; Dag A; Aghamuradov S; Cevirgen SB; Sari S; Bolayirli M; Can G; Hatemi G; Seyahi E; Ozdogan H; Gul A; Ugurlu S
    J Med Virol; 2022 Jul; 94(7):3431-3437. PubMed ID: 35315100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Update on Gout and Calcium pyrophosphate deposition (CPPD)].
    Reuss-Borst M; Tausche AK
    Dtsch Med Wochenschr; 2018 Aug; 143(16):1157-1166. PubMed ID: 30086561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colchicine and new antiinflammatory drugs for the treatment of acute gout.
    Wallace SL
    Arthritis Rheum; 1975; 18(6 Suppl):847-51. PubMed ID: 1201129
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy.
    Molinelli E; Diotallevi F; Simonetti O; Brisigotti V; Sapigni C; Radi G; Campanati A; Offidani A
    Dermatol Ther; 2020 Nov; 33(6):e14256. PubMed ID: 32860474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perplexing pyretic polyarthritis.
    Hanspal RS
    J Miss State Med Assoc; 2010 Apr; 51(4):114-6. PubMed ID: 20827882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.